The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

BTOG 2020 | Where is the management of lung cancer moving?

Name: Where is the management of lung cancer moving?
Uploaded: 2020-01-29T00:00:00Z
Duration: 1 min 26 s
Description: Alan Kirk, FRCS(Glas), FRCPEd, Golden Jubilee National Hospital, Clydebank, Scotland, UK, discusses established and new areas in the management of lung cancer, including surgery, immunotherapy, and screening. This interview took place at the 18th British Thoracic Oncology Group (BTOG) 2020 congress, held in Dublin, UK.

Alan Kirk • 29 Jan 2020

BTOG 2020

Lung Cancer

Alan Kirk, FRCS(Glas), FRCPEd, Golden Jubilee National Hospital, Clydebank, Scotland, UK, discusses established and new areas in the management of lung cancer, including surgery, immunotherapy, and screening. This interview took place at the 18th British Thoracic Oncology Group (BTOG) 2020 congress, held in Dublin, UK.